Articles

A-113 PREVENTABILITY OF SERIOUS ADVERSE DRUG REACTIONS RELATED TO THE USE OF DIRECT ORAL ANTICOAGULANTS: A PROSPECTIVE STUDY

BJH - volume 8, issue Abstract Book BSTH, february 2017

A.-L. Sennesael , A.-S. Larock , B. Devalet , V. Mathieux MD, PhD, F. Verschuren , X. Muschart , O. Dalleur , J-M. Dogné PhD, PharmD, A. Spinewine

Read more

P2.02 Belgian consensus on the diagnosis and management of Paroxysmal Nocturnal Hemoglobinuria

BJH - volume 7, issue Abstract Book BHS, january 2016

B. Devalet , N. Boeckx MD, PhD, B. Chatelain PharmD, C. Chatelain MD, D. Deeren , A. Gothot MD, PhD, S. Meers MD, PhD, T. Devos MD, PhD

Read more

P2.04 Application of a clot based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates

BJH - volume 7, issue Abstract Book BHS, january 2016

B. Devalet , A. Wannez , N. Bailly , L. Alpan , D. Gheldof , J. Douxfils PhD, PharmD, V. Deneys , B. Bihin , B. Chatelain PharmD, J-M. Dogné PhD, PharmD, C. Chatelain MD, F. Mullier PhD, PharmD

Read more

P2.10 Role of Extracellular Vesicles for Thrombosis in Paroxysmal Nocturnal Hemoglobinuria patients

BJH - volume 7, issue Abstract Book BHS, january 2016

W. Wannez , C. Bouvy , B. Devalet , F. Mullier PhD, PharmD, B. Chatelain PharmD, C. Chatelain MD, J-M. Dogné PhD, PharmD

Read more